News Chart J. Molner

Equities

MOLNRIPO

EE3100109034

Delayed Nasdaq Tallinn Other stock markets 07:41:49 2024-06-03 EDT			5-day change	1st Jan Change
13.1 ^EUR	-5.76%		-2.24%	-4.73%

04-30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
03-04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

07177f6c8605fcb62d7b07.FXj3XwDj4bJdVoW-x1niBx1wTmzTvoD5sP9DGMNlGYk.ZACdO1q1kfMZGeztoTqKaGweFA_m28TA9YsAepwdV-9PKMYbUKvQ3zIB7g~3a606eb8553f6db1c83ad6f6f2da8e73